Grail Company
Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
Investors
Number Of Exists:
501-1000
Technology:
Сancer Diagnostics
Industry:
Bioengineering
Founded Date:
2016
Investor Type:
N/A
Employee Number:
201-500
Investment Stage:
N/A
Headquarters:
Menlo Park, California, United States
Estimated Revenue:
$50M to $100M
Funding Status:
M&A